References
- Yelovitch S, Barr HM, Camden J, et al. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y1Receptor agonist. J Med Chem 2012;55:7623–35.
- da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 2016;117:48–54.
- Adinarayana D, Syamasundar KV. A new sesquiterpene alcohol from Pterocarpus marsupium. Phytochemistry 1982;21:1083–5.
- Chakraborty A, Gupta N, Ghosh K, Roy P. In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. Toxicol In Vitro 2010;24:1215–28.
- Pari L, Satheesh MA. Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. Life Sci 2006;79:641–5.
- Sérée E, Burcelin R, Savouret J-F. Le resvératrol en complément thérapeutique: une piste pour la prévention du diabète de type 2? Méd Malad Métabol 2009;3:486–90.
- Azizzadeh B, Yip HT, Blackwell KE, et al. Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 2001;111:1896–900.
- Huerta S, Chilka S, Bonavida B. Nitric oxide donors: novel cancer herapeutics (Review). Int J Oncol 2008;33:909.
- Agurla S, Gayatri G, Raghavendra AS. Nitric oxide as a secondary messenger during stomatal closure as a part of plant immunity response against pathogens. Nitric Oxide 2014;43:89–96.
- Wang B, Li N, Liu T, et al. Research progress on synthesis of nitric oxide donor compounds. Chin J Org Chem 2017;37:777.
- Burgaud J-L, Ongini E, Soldato P. Nitric oxide-releasing drugs. Ann N Y Acad Sci 2002;962:360–71.
- Bhandari SV, Bothara KG, Patil AA, et al. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach. Bioorg Med Chem 2009;17:390–400.
- Tarasenko O, Scott A, Soderberg L, et al. Killing of Bacillus spores is mediated by nitric oxide and nitric oxide synthase during glycoconjugate-enhanced phagocytosis. Glycoconjug J 2009;27:13–25.
- Etgen GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 1997;46:1915–9.
- Young ME, Radda GK, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 1997;322:223–8.
- Kaddai V, Gonzalez T, Bolla M, et al. The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes. Am J Physiol: Endocrinol Metab 2008;295:E162–9.
- Liu D, He W, Wang Z, et al. Design, synthesis and biological evaluation of 3licylic acid,analogs of 3′-epi-neoponkoranol as potent α-glucosidase inhibitors. Eur J Med Chem 2016;110:224–36.
- Trapero A, Llebaria A. A prospect for pyrrolidine iminosugars as antidiabetic α-glucosidase inhibitors. J Med Chem 2012;55:10345–6.
- Ni Z, Zhuge Z, Li W, et al. Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation end products in vitro. Biol Pharm Bull 2012;35:2050–3.
- Derbré S, Gatto J, Pelleray A, et al. Automating a 96-well microtiter plate assay for identification of AGEs inhibitors or inducers: application to the screening of a small natural compounds library. Anal Bioanal Chem 2010;398:1747–58.
- Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129–46.
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20.
- Khan Z, Chakrabarti S. Therapeutic targeting of endothelial dysfunction in chronic diabetic complications. Recent Pat Cardiovasc Drug Discov 2006;1:167–75.
- La Motta C, Sartini S, Mugnaini L, et al. Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity. J Med Chem 2007;50:4917–27.
- Hwang YC. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J 2004;18:1192–9.
- Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol 1983;54:275–87.
- Mata R, Cristians S, Escandón-Rivera S, et al. Mexican antidiabetic herbs: valuable sources of inhibitors of α-glucosidases. J Nat Prod 2013;76:468–83.
- Liu J, Liu Q, Yang X, et al. Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates. Bioorg Med Chem 2013;21:7742–51.
- Khan KM, Qurban S, Salar U, et al. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives. Bioorg Chem 2016;68:245–58.
- Wang B, Li N, Liu T, et al. Synthesis and biological evaluation of novel neoflavonoid derivatives as potential antidiabetic agents. RSC Adv 2017;7:34448–60.
- Chethan S, Dharmesh SM, Malleshi NG. Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols. Bioorg Med Chem 2008;16:10085–90.
- Cristians S, Mata R, Bye R. Phenological and geographical influence in the concentration of selected bioactive 4-phenylcoumarins and chlorogenic acid in Hintonia latiflora leaves. J Ethnopharmacol 2014;152:308–13.
- Guerrero-Analco J, Medina-Campos O, Brindis F, et al. Antidiabetic properties of selected Mexican copalchis of the Rubiaceae family. Phytochemistry 2007;68:2087–95.